Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Bombardier Global 8000 Enters Service - 2Vote in favor of the subject that you see as generally captivating and intelligent!
- 3King Charles shares cancer treatment update, says it's a 'personal blessing'
- 4Instructions to Adjust Work, Life, and Seeking after a Web based Advertising Degree
- 5'The Golden Bachelor' Season 2 finale: How to watch tonight, start time, where to stream and more
- Zelensky names spy chief to head presidential office after corruption row
- Instructions to Clean and Really focus on Your Lab Precious stone
- Figure out How to Amplify the Resale Worth of Your Kona SUV
- Find the Insider facts of Compelling Systems administration: Building Associations for Progress
- Dominating the Remote Work Way of life: Individual Systems
- Make your choice for the bird that catches your heart!
- Americans generally like wolves − except when we’re reminded of our politics
- Cases of norovirus are on the rise just in time for the holiday season
- Pat Finn, actor from 'The Middle,' dies at 60 after bladder cancer diagnosis
